Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
21. August 2024 10:50 ET
|
Schall Law
Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
14. August 2024 11:30 ET
|
Schall Law
Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
07. August 2024 12:20 ET
|
Schall Law
Investors Have Opportunity to Lead Late Stage Asset Management, LLC Securities Fraud Lawsuit with the Schall Law Firm
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
31. Mai 2024 08:36 ET
|
Ocugen
Established Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical TrialDSMB Recommends Continuing with High-Dose Cohort Dosing with Concurrent Phase 2 Dosing MALVERN, Pa., May 31, 2024 ...
Euro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020
30. Oktober 2020 06:00 ET
|
Cromos Pharma; Avance Clinical
DUBLIN, Ireland and ADELAIDE, Australia, Oct. 30, 2020 (GLOBE NEWSWIRE) -- Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in...
Blue Cloud Ventures Announces Success of First Fund
09. September 2014 13:00 ET
|
Blue Cloud Ventures
NEW YORK, NY--(Marketwired - Sep 9, 2014) - Blue Cloud Ventures (BCV), a growth and late stage co-investment fund that focuses on cloud-based enterprise software companies, announced today the...